PCP (Phencyclidine)
NMDA receptor antagonist and dissociative anesthetic. Highly lipophilic with large volume of distribution, leading to prolonged effects and detection window. Half-life ~21 hours but can extend to 72 hours at overdose. Detectable in urine for 1-2 weeks in chronic users.
Projected serum levels — 5 mg, as needed (shown daily)
Maintenance schedule: 5 mg as needed (shown daily) (oral).
Loading schedule: 11.4 mg on day 1, then 5 mg as needed (shown daily) — reaching therapeutic levels sooner.
Modeled steady state after ~3 days: peak ≈ 7.5 mg, trough ≈ 4.5 mg body load. Population-based estimate over 15 days for a 5 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Dissociative
- Route modeled
- Oral
- Model confidence
- inferred
- Half-life
- 20 h
- Common dose
- 5 mg
- Reference dose range
- 2.5–10 mg (single dose)
- Suggested cadence
- as needed (shown daily)
- Validated against
- 5 mg oral — Cmax 0.007 mg/L at 1.5 h
Documented interactions
-
contraindicated
Efavirenz (Sustiva) + PCP (Phencyclidine)
Efavirenz (Sustiva) inducer of CYP3A4 predicted to change PCP (Phencyclidine) AUC by ~0.19x
-
contraindicated
Rifampin + PCP (Phencyclidine)
Rifampin inducer of CYP3A4 predicted to change PCP (Phencyclidine) AUC by ~0.19x
-
danger
Amphetamine (Adderall) + PCP (Phencyclidine)
PCP + stimulants causes extreme cardiovascular strain, psychosis, hyperthermia, and seizure risk.
-
danger
Carbamazepine (Tegretol) + PCP (Phencyclidine)
Carbamazepine (Tegretol) inducer of CYP3A4 predicted to change PCP (Phencyclidine) AUC by ~0.29x
-
danger
Clarithromycin (Biaxin) + PCP (Phencyclidine)
Clarithromycin (Biaxin) mechanism_based of CYP3A4 predicted to change PCP (Phencyclidine) AUC by ~2.29x
-
danger
Cocaine + PCP (Phencyclidine)
PCP + cocaine causes severe cardiovascular strain, psychosis, and seizure risk.
Serum checks 103 modeled interaction pairings for pcp (phencyclidine) across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.
Research behind this entry
-
Phencyclidine Disposition after Intravenous and Oral Doses
Administered radiolabeled PCP IV and orally to healthy men, finding 73% urinary recovery, 16% as unchanged PCP, with hydroxylated metabolite conjugates comprising 31% of urinary radioactivity.
-
Urine pH and Phencyclidine Excretion
Showed acidification of urine dramatically increased PCP renal clearance compared to alkaline urine, supporting ion-trapping mechanism for this weak base (pKa 8.5).
2 published studies referenced in the app, each with a plain-language summary.